tDCS and Speech Therapy to Improve Aphasia "MP-LOGA"


Phase N/A Results N/A

Summary of Purpose

To study the effect of combined tDCS plus speech therapy compared to sham-tDCS plus speech therapy in subacute stroke patients suffering from moderate or severe aphasia. The patients will be randomized by a computer-generated lot. Assessment will be performed at study onset, after six weeks at the end of the specific intervention and 4 months after stroke onset for follow-up.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 September 2016.

1 May 2015 11 Mar 2015 1 Apr 2018 1 Oct 2018 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment